CIK 0001604464
- Non-accelerated filer
- Smaller reporting company
Atara Biotherapeutics, Inc.
Sign in to watch- Ticker
- ATRA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 460920988
- Phone
- +1 805-623-4211
- Business address
- 1280 RANCHO CONEJO BLVD, THOUSAND OAKS, CA, 91320
- 4 Open-market sale EVP, Head of R&D sold 5,184 shares at $14.55 ($75,427)
- 4 Open-market sale SVP, GC & Secretary sold 5,681 shares at $14.55 ($82,659)
- 4 Open-market sale President and CEO sold 8,313 shares at $14.55 ($120,954)
- 4 Open-market sale Chief Financial Officer sold 3,616 shares at $14.55 ($52,613)
- 4 Open-market sale Chief Commercial Officer sold 761 shares at $14.55 ($11,073)
- 4 Open-market sale Chief Operations Officer sold 3,500 shares at $15.00 ($52,500)
- 4 Open-market sale Chief Operations Officer sold 655 shares at $14.74 ($9,655)
- 4 Open-market sale Chief Financial Officer sold 1,761 shares at $14.58 ($25,675)
- 4 Open-market sale Chief Operations Officer sold 2,640 shares at $14.58 ($38,491)
- 4 Open-market sale Chief Operations Officer sold 7,000 shares at $17.41 ($121,870)
- 4 Open-market sale Chief Operations Officer sold 1,665 shares at $16.74 ($27,872)
- 4 Open-market sale Chief Financial Officer sold 1,461 shares at $16.74 ($24,457)
- 4 Open-market sale President and CEO sold 4,887 shares at $16.74 ($81,808)
- 4 Grant or award EVP, Head of R&D acquired 53,879 shares (grant or award)
- 4 Grant or award SVP, GC & Secretary acquired 41,756 shares (grant or award)
- 4 Grant or award Chief Operations Officer acquired 37,715 shares (grant or award)
- 4 Grant or award Chief Commercial Officer acquired 35,021 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 45,258 shares (grant or award)
- 4 Grant or award President and CEO acquired 117,187 shares (grant or award)
- 4 Open-market sale Chief Financial Officer sold 1,759 shares at $20.39 ($35,866)
Page 10 of 33 · 645 filings